期刊文献+

HIF-2α基因与人肺腺癌A549细胞株对顺铂耐药性的关系 被引量:1

Relationship between HIF-2α Gene and Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
下载PDF
导出
摘要 目的:探讨小干扰RNA(small interfering RNA,siRNA)沉默缺氧诱导因子2α(hypoxia inducible factor-2 alpha,HIF-2α)基因表达后,人肺腺癌A549细胞株对顺铂耐药性的变化。方法:构建靶向HIF-2α基因的siRNA真核表达载体并转染A549细胞,采用Real-time PCR检测HIF-2αmRNA的表达,采用Western blotting检测HIF-2α及多药耐药基因1(multidrug resistance-1,Mdr-1)蛋白的表达,采用MTT法检测顺铂处理后细胞的存活率。结果:在HIF-2αsiRNA转染A549细胞后24、48 h后,HIF-2α在mRNA和蛋白水平的表达与空白对照组相比均显著下调(均P<0.01),Mdr-1蛋白的表达水平也明显降低(均P<0.05)。与空白对照组相比,HIF-2αsiRNA组细胞对顺铂的敏感性明显增加,各时间点的IC50值均显著降低,差异有统计学意义(均P<0.01)。结论:靶向HIF-2α的siRNA表达载体能够有效抑制HIF-2α基因的表达,从而逆转A549细胞对顺铂的化疗耐药性。 Objective:To investigate the effect of silencing hypoxia inducible factor-2 alpha (HIF-2α) gene expression by small interfering RNA (siRNA) on chemotherapy resistance of A549 cells to cisplatin.Methods:The siRNA eukaryotic expression vectors targeting HIF-2α gene were constructed and transfected into A549 cells.The expression of HIF-2α mRNA was detected by real-time PCR.The expression of HIF-2α and multidrug resistance-1 (Mdr-1) proteins were detected by Western blotting.MTT assay was used to explore the survival rate of A549 cells under the treatment of cisplatin.Results:After transfection of HIF-2α siRNA into A549 cells for 24 and 48 h,the expression levels of HIF-2α mRNA and protein were both down-regulated significantly compared with those in the blank group (all P<0.01).Meanwhile,the protein expression level of Mdr-1 also decreased significantly (all P<0.05).The sensitivity of A549 cells to cisplatin was significantly increased in HIF-2α siRNA transfection group compared with that in the blank group.The IC50 value at each time point was significantly decreased,and the difference was statistically significant (all P<0.01).Conclusions:The siRNA expression vector targeting HIF 2α constructed in this study can effectively inhibit the expression of HIF-2α gene,and thus reversing the chemotherapy resistance of A549 cells to cisplatin.
出处 《中国临床医学》 2013年第6期772-775,共4页 Chinese Journal of Clinical Medicine
基金 江苏省常州市卫生局青年基金项目(编号:QN201003)
关键词 肺腺癌 化疗耐药 缺氧诱导因子-2Α 小干扰RNA 多药耐药基因1 Lung adenocarcinoma Chemotherapy resistance Hypoxia inducible factor-2 alpha Small interfering RNA Multidrug resistance-1
  • 相关文献

二级参考文献55

  • 1Parkin DM. Global cancer statistics in the year 2000[J]. Lancet Oncol, 2001, 2:533-543.
  • 2Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007[J].CA Cancer J Clin, 2007, 57: 43-66.
  • 3Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000[J]. Int J Cancer, 2001, 94: 153-156.
  • 4Giatromanolaki A, Koukourakis MI, Sivridis E, et al. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non small cell lung cancer to angiogenic/molecular profile of tumours and survival[J]. BrJ Cancer, 2001, 85:881-890.
  • 5Dworakowska D, Gozdz S, Jassem E. et al. Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non- small cell lung cancer[J]. Lung Cancer, 2002. 35: 35-41.
  • 6Gatenby RA, Kessler HB, Rosenblum JS, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy[J].Int J Radiat Oncol Biol Phys, 1988, 14:831-838.
  • 7Harris AL. Hypoxia-a key regulatory factor in tumour growth [J]. Nat Rev Cancer, 2002, 2:38-47.
  • 8Wang V, Davis DA, Haque M, et al. Differential gene up-regulation by hypoxia-inducible faetor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells[J]. Cancer Res, 2005, 65:3299-3306.
  • 9Dachs GU,Patterson AV,Firth JD,et al.Targeting gene expression to hypoxic tumor cells.Nat Med,1997,3:515-520.
  • 10Sato M,Tanaka T,Maemura K,et al.The pai-1 gene as a direct target of endothelial pas domain protein-1 in adenocarcinoma a549 cells.Am J Respir Cell Mol Biol,2004,31:209-215.

共引文献38

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部